Mizied Falah
Direttore Tecnico/Scientifico/R&S presso VESSL Therapeutics Ltd.
Profilo
Mizied Falah was the founder of GeneArrest Ltd., a company founded in 2009, where he held the title of Chief Technology Officer.
He is currently working at VESSL Therapeutics Ltd.
as the Director of Strategic Research & Development since 2013.
Dr. Falah obtained a doctorate degree from McMaster University in 1997 and completed undergraduate and graduate studies at The Hebrew University of Jerusalem.
Posizioni attive di Mizied Falah
| Società | Posizione | Inizio |
|---|---|---|
VESSL Therapeutics Ltd.
 VESSL Therapeutics Ltd. Medical SpecialtiesHealth Technology VESSL Therapeutics Ltd. develops cell-based therapies for large patient populations. Its solutions include MultiGeneAngio fo Peripheral Artery Disease and MultiGeneGraft for end-stage renal disease. The company was founded in August 2000 by Moshe Y. Flugelman and Basil S. Lewis and is headquartered in Haifa, Israel. | Direttore Tecnico/Scientifico/R&S | - |
Precedenti posizioni note di Mizied Falah
| Società | Posizione | Fine |
|---|---|---|
GeneArrest Ltd.
 GeneArrest Ltd. Miscellaneous Commercial ServicesCommercial Services GeneArrest Ltd. develops drug discovery technology. Its antigene drug discovery platform is a route to capitalize on new insights in genomic information to make novel drugs. The company's technology is based on proprietary bioinformatics tools used to design selective and specific gene-silencing chemicals. GeneArrest was founded by Mizied Falah and Anwar Rayan in 2009 and is headquartered in Nazareth, Israel. | Fondatore | - |
Formazione di Mizied Falah
| McMaster University | Doctorate Degree |
| The Hebrew University of Jerusalem | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
VESSL Therapeutics Ltd.
VESSL Therapeutics Ltd. Medical SpecialtiesHealth Technology VESSL Therapeutics Ltd. develops cell-based therapies for large patient populations. Its solutions include MultiGeneAngio fo Peripheral Artery Disease and MultiGeneGraft for end-stage renal disease. The company was founded in August 2000 by Moshe Y. Flugelman and Basil S. Lewis and is headquartered in Haifa, Israel. | Health Technology |
GeneArrest Ltd.
GeneArrest Ltd. Miscellaneous Commercial ServicesCommercial Services GeneArrest Ltd. develops drug discovery technology. Its antigene drug discovery platform is a route to capitalize on new insights in genomic information to make novel drugs. The company's technology is based on proprietary bioinformatics tools used to design selective and specific gene-silencing chemicals. GeneArrest was founded by Mizied Falah and Anwar Rayan in 2009 and is headquartered in Nazareth, Israel. | Commercial Services |
- Borsa valori
- Insiders
- Mizied Falah
